UroGen Pharma Ltd. short interest in 2023
In 2023, UroGen Pharma Ltd.'s disclosed short interest ran from 2.47% of shares outstanding on 13 Jan 2023 to 11.49% on 29 Dec 2023, a change of +9.02 percentage points. The year's high was 11.49% on 29 Dec 2023 and its low 2.47% on 13 Jan 2023, averaging 4.97% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 13.43 days on 29 Dec 2023. Full history: UroGen Pharma Ltd..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2023 in figures
- Start of year
- 2.47% (13 Jan 2023)
- End of year
- 11.49% (29 Dec 2023)
- Change
- +9.02 pp
- High
- 11.49% (29 Dec 2023)
- Low
- 2.47% (13 Jan 2023)
- Average
- 4.97%
- Highest days to cover
- 13.43 (29 Dec 2023)
- SEC filings marked
- 8
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 13 Jan 2023 | 2.47% | 4.94 | |
| 31 Jan 2023 | 2.47% | 4.56 | |
| 15 Feb 2023 | 2.50% | 6.23 | |
| 28 Feb 2023 | 2.57% | 5.79 | |
| 15 Mar 2023 | 2.71% | 8.61 | |
| 31 Mar 2023 | 2.73% | 3.96 | results (8-K), 10-K filed |
| 14 Apr 2023 | 3.17% | 6.61 | |
| 28 Apr 2023 | 3.12% | 3.12 | |
| 15 May 2023 | 4.03% | 2.52 | 10-Q filed, results (8-K) |
| 31 May 2023 | 3.64% | 7.23 | |
| 15 Jun 2023 | 2.80% | 4.75 | |
| 30 Jun 2023 | 3.88% | 2.01 | |
| 14 Jul 2023 | 4.32% | 4.98 | |
| 31 Jul 2023 | 6.70% | 1.00 | |
| 15 Aug 2023 | 5.49% | 2.43 | 10-Q filed, results (8-K) |
| 31 Aug 2023 | 4.65% | 2.93 | |
| 15 Sep 2023 | 4.27% | 6.65 | |
| 29 Sep 2023 | 4.73% | 8.30 | |
| 13 Oct 2023 | 5.43% | 7.78 | |
| 31 Oct 2023 | 7.56% | 8.15 | |
| 15 Nov 2023 | 9.16% | 10.64 | 10-Q filed, results (8-K) |
| 30 Nov 2023 | 9.45% | 10.53 | |
| 15 Dec 2023 | 9.95% | 9.38 | |
| 29 Dec 2023 | 11.49% | 13.43 |
See also: UroGen Pharma Ltd.'s full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.